Remdesivir in a pregnant patient with COVID-19 pneumonia. Issue 1 (2nd January 2021)

• Record Type: Journal Article
• Authors: Dande, Ranadheer; Qureshi, Anum; Persaud, Kia; Puri, Chahat; Zulfiqar, Sajida; Awasthi, Shankar
• Is Part Of: Journal of community hospital internal medicine perspectives. Volume 11:Issue 1(2021)
• Page Start: 103
• Page End: 106
• Publication Date: 2021-01-02
• Subjects: COVID-19 pneumonia -- pregnancy -- Remdesivir -- hydroxychloroquine; Internal medicine -- Periodicals; Hospitals -- Periodicals; Hospitals, Community; Internal Medicine; Hospitals; Internal medicine; Periodicals; Periodicals; 610
• DOI: 10.1080/20009666.2020.1857510
• Languages: English
• ISSNs: 2000-9666

Abstract

ABSTRACT: Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.